AHCL

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹15.73

+0.83% today · 30d +11.32%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for AHCL. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹36 Cr

NET PROFIT

₹5 Cr

OPM

35.06%

EPS

₹1.13

PE 22.43

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

AHCL22.43—

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance — —

Valuation REASONABLE 60

Growth STRONG 82

Profitability HIGH 95

Technicals NEUTRAL 65

Risk MODERATE 60

Key Stats

TTM PE

22.43

P/B

3.03

52W HIGH

₹17.28

OFF HIGH

-8.94%

MKT CAP

₹838 Cr

◉ Active Signals

MACDBullish0.1069

RSI(14)Bullish60.08

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AHCL and at what entry.